Chemopreventive Effect of PSP Through Targeting of Prostate Cancer Stem Cell-Like Population
Open Access
- 16 May 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (5), e19804
- https://doi.org/10.1371/journal.pone.0019804
Abstract
Recent evidence suggested that prostate cancer stem/progenitor cells (CSC) are responsible for cancer initiation as well as disease progression. Unfortunately, conventional therapies are only effective in targeting the more differentiated cancer cells and spare the CSCs. Here, we report that PSP, an active component extracted from the mushroom Turkey tail (also known as Coriolus versicolor), is effective in targeting prostate CSCs. We found that treatment of the prostate cancer cell line PC-3 with PSP led to the down-regulation of CSC markers (CD133 and CD44) in a time and dose-dependent manner. Meanwhile, PSP treatment not only suppressed the ability of PC-3 cells to form prostaspheres under non-adherent culture conditions, but also inhibited their tumorigenicity in vivo, further proving that PSP can suppress prostate CSC properties. To investigate if the anti-CSC effect of PSP may lead to prostate cancer chemoprevention, transgenic mice (TgMAP) that spontaneously develop prostate tumors were orally fed with PSP for 20 weeks. Whereas 100% of the mice that fed with water only developed prostate tumors at the end of experiment, no tumors could be found in any of the mice fed with PSP, suggesting that PSP treatment can completely inhibit prostate tumor formation. Our results not only demonstrated the intriguing anti-CSC effect of PSP, but also revealed, for the first time, the surprising chemopreventive property of oral PSP consumption against prostate cancer.Keywords
This publication has 38 references indexed in Scilit:
- Gamma‐tocotrienol as an effective agent in targeting prostate cancer stem cell‐like populationInternational Journal of Cancer, 2011
- Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT–Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer SpecimensCancer Research, 2007
- Garlic-DerivedS-allylmercaptocysteine Is a NovelIn vivoAntimetastatic Agent for Androgen-Independent Prostate CancerClinical Cancer Research, 2007
- Advances in the Treatment of Prostate CancerAnnual Review of Medicine, 2007
- Mechanisms of action of novel agents for prostate cancer chemopreventionEndocrine-Related Cancer, 2006
- Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cellsOncogene, 2006
- Prospective Identification of Tumorigenic Prostate Cancer Stem CellsCancer Research, 2005
- A Tumorigenic Subpopulation with Stem Cell Properties in MelanomasCancer Research, 2005
- Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer modelGene Therapy, 2002
- Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells.International Journal of Oncology, 2001